INS and metabolic dysfunction-associated steatotic liver disease: However, suppressing adiposeness by stimulating peripheral insulin action, as well as treatment with anti-inflammatory and antioxidant drugs, has shown very promising results in alleviating NAFLD and its complications in both humans and animals [9].